Switch to HPV screening will spare many from surgery

The switch to HPV-based cervical screening in December will reduce a woman’s lifetime risk of cervical surgery compared with the current Pap test program, cancer researchers say.

With the new screening program, women vaccinated against HPV will be at a 13% lower risk of cervical surgery over their lifetime compared with their risk if Pap smear screening was maintained, according to Professor Karen Canfell, director of research at Cancer Council NSW.

An additional benefit is a decrease in the number of pregnancy complications that